Study of Frailty and Recovery in Women with Newly Diagnosed Gynecologic Cancer

What this Trial Is About

Researchers are studying how frailty, a condition that makes people more vulnerable to health stressors, affects outcomes and quality of life in adults newly diagnosed with gynecologic cancer. The study aims to assess risk factors linked to frailty and compare quality of life, surgical, and cancer-related outcomes between patients who are frail and those who are not. This observational study involves participants from gynecologic oncology services at two institutions. Participants will take part in physical function assessments and complete quality of life surveys before their standard surgery for cancer. After surgery, they will be followed for at least three months and up to one year to monitor recovery and quality of life. Additionally, medical records will be reviewed periodically for up to 10 years to assess long-term cancer outcomes, including survival and treatment delays. During the study, participants will undergo regular physical and self-reported evaluations every three months, along with medical record reviews. Researchers will measure frailty at enrollment and track outcomes such as length of hospital stay, readmissions, surgical complications, and chemotherapy timing. Long-term follow-up will assess progression-free and overall survival, as well as treatment delays. The total participation time may extend to 10 years for some assessments.

PROmOting Gynecologic Cancer Patients With Frailty to Achieve Functional Recovery